Acadia Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
ALKERMES USD 1.48B 63.7M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Biogen USD 7.63B 169.2M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Cytokinetics USD 956.05M 151.89M 2025-03
Eisai JPY 761.1B 79.19B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Incyte USD 3.23B 7.24M 2025-03
J&J USD 71.55B 15.66B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Prothena USD 485.41M 49.57M 2024-12
PTC Therapeutics USD 2.32B 950.88M 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Acadia Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.